A new study by Geisel researchers, which appears in the journal Biological Psychiatry, is shedding new light into the neurobiological basis of autism spectrum disorders.
The Geisel School of Medicine and Dartmouth-Hitchcock are partnering with Brigham and Women’s Hospital as one of four centers in a new American Heart Association-funded research network charged with unlocking some of the mysteries behind vascular disease.
Noted molecular biologist James Bliska, PhD, is joining the Geisel School of Medicine at Dartmouth as a Distinguished Professor in Microbiology and Immunology and senior lead faculty member of the Personalized Treatments for Cystic Fibrosis (CF) Cluster, a cross-Dartmouth group of investigators established to develop innovative, personalized medicine and treatments for CF and lung infections caused by opportunistic pathogens.
Two outstanding graduate student researchers at the Geisel School of Medicine, Heidi Chapman and Riley Hampsch, are gaining knowledge and skills in the biotechnology sector as recipients of 2017 Dartmouth SYNERGY/Celdara Medical High-Potential Entrepreneurs’ Fellowships.
Geisel Professor Rahul Sarpeshkar, PhD is one of three Dartmouth faculty being honored as 2018 Fellows of the Institute of Electrical and Electronics Engineers, the world’s leading professional association for advancing technology for humanity.
A Dartmouth-led study found that social media big data can be used to understand communication and behavioral patterns related to prescription drug abuse.
A team of Geisel researchers will receive funding from the Patient-Centered Outcomes Research Institute (PCORI) to design new methods for comparing the effectiveness of alternative therapies that can lead to improvements in practice and better outcomes for patients.
Geisel researchers take a close look at New Hampshire’s complex opioid epidemic, and one city’s novel response.
Dartmouth-led research is in early phase drug discovery and finds promising therapeutic leads after targeting vulnerabilities in nervous system tumors, including glioblastoma.
Dartmouth SYNERGY Scholars prepares young clinical scientists for success in today’s highly competitive research environment.